IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 573 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  Search
 
  Next article
  Previous article 
  Table of Contents
  
Resource Links
   Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
   Article in PDF (163 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)

 
In This Article
   References

 Article Access Statistics
    Viewed1609    
    Printed56    
    Emailed0    
    PDF Downloaded83    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

 


 
LETTER TO THE EDITOR
Year : 2010  |  Volume : 42  |  Issue : 6  |  Page : 421
 

Very-low-birth-weight infants, prophylactic micafungin or fluconazole


Department of Pediatrics and Immunodeficiencies, Hospital 12 octubre, Carretera Andalucia km 5,400, Postal code 28041, Madrid, Spain

Date of Web Publication21-Oct-2010

Correspondence Address:
Luis Gonzalez-Granado
Department of Pediatrics and Immunodeficiencies, Hospital 12 octubre, Carretera Andalucia km 5,400, Postal code 28041, Madrid
Spain
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0253-7613.71904

Rights and Permissions



How to cite this article:
Gonzalez-Granado L. Very-low-birth-weight infants, prophylactic micafungin or fluconazole. Indian J Pharmacol 2010;42:421

How to cite this URL:
Gonzalez-Granado L. Very-low-birth-weight infants, prophylactic micafungin or fluconazole. Indian J Pharmacol [serial online] 2010 [cited 2020 Jul 3];42:421. Available from: http://www.ijp-online.com/text.asp?2010/42/6/421/71904


Sir,

I read with great interest the article by Grover in a previous issue of the journal. [1] The author states that micafungin is approved for prophylaxis of candida infections in patients undergoing hematopoietic stem cell transplant (HSCT). It is not the only the use of prophylactic micafungin, but also it also prevents candida infection in very-low-birth-weight preterm neonates. The authors support the idea of micafungin as a second-line treatment after failure with fluconazole. However, both drugs have been assessed and the comparison in prophylaxis is favorable to micafungin. [2]

The pharmacokinetic profile of micafungin in very-low-birth-weight preterms has been studied, and its safety and efficacy in that population has been confirmed. [3] As it has been reported, the efficacy of micafungin in the clearance of candida infection compared with fluconazole is favorable to micafungin. [4] Therefore, we should recognize that micafungin is at least an alternative to fluconazole as the preferred drug for antifungal prophylaxis in very-low-birth-weight preterm patients.

 
  References Top

1.Grover ND. Echinocandins: A ray of hope in antifungal drug therapy. Indian J Pharmacol 2010;42:9-11.  Back to cited text no. 1  [PUBMED]  Medknow Journal  
2.Sohn HS, Lee TJ, Kim J, Kim D. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea. Clin Ther 2009;31:1105-15.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]  
3.Kawada M, Fukuoka N, Kondo M, Okazaki K, Kusaka T, Kawada K, et al. Pharmacokinetics of prophylactic micafungin in very-low-birth-weight infants. Pediatr Infect Dis J 2009;28:840-2.  Back to cited text no. 3  [PUBMED]    
4.Warn PA, Sharp A, Morrissey G, Denning DW. In vivo activity of micafungin in apersistently neutropenic murine model of disseminated infection caused by Candida tropicalis. J Antimicrob Chemother 2002;50:1071-4.  Back to cited text no. 4  [PUBMED]  [FULLTEXT]  



This article has been cited by
1 Echinocandins: A ray of hope in antifungal drug therapy
Grover, N.D.
Indian Journal of Pharmacology. 2010; 42(6): 422
[Pubmed]



 

Top
Print this article  Email this article

    

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow